Provided by Tiger Fintech (Singapore) Pte. Ltd.

INmune Bio Inc

8.12
-0.0200-0.25%
Post-market: 8.07-0.0465-0.57%18:07 EDT
Volume:218.49K
Turnover:1.76M
Market Cap:180.04M
PE:-3.72
High:8.18
Open:8.00
Low:7.89
Close:8.14
Loading ...

INmune Bio initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
28 Jan

INmune Bio treatment of epidermolysis bullosa receives FDA orphan designation

TIPRANKS
·
07 Jan

Institutions along with retail investors who hold considerable shares inINmune Bio, Inc. (NASDAQ:INMB) come under pressure; lose 11% of holdings value

Simply Wall St.
·
17 Dec 2024

INmune Bio Inc. Completes Repayment of Silicon Valley Bank Debt

GlobeNewswire
·
10 Dec 2024

OmniScience and INmune Bio Partner for Alzheimer’s Trial

Exec Edge
·
05 Dec 2024

INmune Bio Partners With OmniScience to Accelerate Alzheimer's Trial

MT Newswires Live
·
05 Dec 2024

INmune Bio, OmniScience announce partnership to accelerate Alzheimer’s trial

TIPRANKS
·
04 Dec 2024

BRIEF-OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial with Vivo, a Novel genAI Clinical Trial Control Tower

Reuters
·
04 Dec 2024

Omniscience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial With Vivo, a Novel Genai Clinical Trial Control Tower

THOMSON REUTERS
·
04 Dec 2024

INmune Bio announces enrollment of 208 patients in Phase 2 trial of early AD

TIPRANKS
·
13 Nov 2024

BRIEF-Inmune Bio Inc. Announces Final Enrollment Of 208 Patients In Phase 2 Trial In Early Alzheimer's Disease

Reuters
·
13 Nov 2024

INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease

THOMSON REUTERS
·
13 Nov 2024

INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease

GlobeNewswire
·
13 Nov 2024

INmune Bio Third Quarter 2024 Earnings: US$0.60 loss per share (vs US$0.48 loss in 3Q 2023)

Simply Wall St.
·
03 Nov 2024

INmune Bio Inc (INMB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...

GuruFocus.com
·
01 Nov 2024

INmune Bio Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
01 Nov 2024